Benefits & Executive Compensation News
View and Filter All Stories

Latest Stories

Newell Brands Securities Suit Over Jarden Purchase Tossed Again

Newell Brands Inc. convinced the Third Circuit Tuesday to affirm the dismissal of a federal securities class action brought on behalf of purchasers of Newell stock who said company executives issued false and misleading financial guidance in connection with the $15.3 billion acquisition of competitor Jarden Corp.

Abbvie, Amgen Kickback Suit Dismissal Affirmed by Second Circuit

The U.S. Justice Department was right to seek dismissal of a whistleblower’s False Claims Act suit against pharmaceutical manufacturers and pharmacy benefit managers including Abbvie Inc., Amgen Inc., Aetna Inc., and Cigna Corp., among others, the Second Circuit affirmed Tuesday.

Teva’s $2.55 Million ERISA Settlement Denied Early Approval

Teva Pharmaceuticals USA Inc.‘s $2.55 million settlement with employees challenging the company’s 401(k) plan failed to receive preliminary court approval. A Philadelphia federal judge said he may sign off on the deal after the parties rethink aspects of their allocation and notification plans.

View More